Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody. (2022)

First Author: Dangi T

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci162282

PubMed Identifier: 36219482

Publication URI: http://europepmc.org/abstract/MED/36219482

Type: Journal Article/Review

Volume: 132

Parent Publication: The Journal of clinical investigation

Issue: 23

ISSN: 0021-9738